Articles related to ATRIAL FIBRILLATION (AFIB)
Comparative Effectiveness and Safety Between Apixaban, Dabigatran, Edoxaban, and Rivaroxaban Among Patients with Atrial Fibrillation
Medical records of more than half a million individuals in the EU, UK, and US were evaluated. Apixaban was the most frequently prescribed direct oral anticoagulant (DOAC) for AFib. It was also associated with a lower incidence of GI bleed vs. the other DOACs.
Cardiology November 9th 2022
1 in 20 Patients Hospitalized with COVID Develop AFib
According to new information revealed in a study of the AHA’s COVID-19 Cardiovascular Disease Registry, new onset AFib occurs in 5% of patients hospitalized with COVID-19. Patients who developed new-onset AFib experienced longer hospital stays and approximately 45% died during their hospitalization. Atrial fibrillation can directly increase the risk of stroke and prolong hospitalization. It is also an indirect marker of the insult that the heart is experiencing when patients are infected with COVID-19.
Cardiology October 27th 2022
Atrial Fibrillation: Rate Control or Rhythm Control?
Atrial fibrillation (AF) can be managed by either a rate control or a rhythm control strategy. Data as to whether rate control or a rhythm control provides better clinical outcomes have been mixed. Therefore, even if direct evidence from randomized clinical trials is lacking in many types of patients, given the unpredictable long-term adverse effects of atrial fibrillation, rhythm control is generally the goal.
Cardiology October 26th 2022
Apixaban vs. Rivaroxaban in Patients with Atrial Fibrillation and Valvular Heart Disease
When compared with rivaroxaban in a propensity score–matched cohort of 19,894 patients, apixaban was associated with an approximately 50% lower rate of ischemic stroke or systemic embolism and bleeding compared to rivaroxaban.
Cardiology October 26th 2022
Top 10 Calculators from MDCalc
In reverse order of popularity: 10. PECARN Pediatric Head Injury/Trauma Algorithm9. GAD-7 (General Anxiety Disorder-7)8. Ideal Body Weight and Adjusted Body Weight7. Steroid Conversion Calculator6. Calcium Correction for Hypoalbuminemia5. MELD Score (Model For End-Stage Liver Disease) (12 and older)4. Mean Arterial Pressure (MAP)3. CHA₂DS₂-VASc Score for Atrial Fibrillation Stroke Risk2. PHQ-9 (Patient Health Questionnaire-9)1. Creatinine Clearance (Cockcroft-Gault Equation)
All Specialties October 6th 2022
New Studies Analyze Risk Factors, Treatments for Afib
A UK study reports that a history of irregular menstrual cycle was associated with higher risk for afib in women. A finding from the Vitamin D and Omega 3 Trial (VITAL) Rhythm Study reveals that when controlled for height and body size, women are at higher risk than men for afib, suggesting that biological sex and body size account for much of the protective effect of female sex. And as separately reported, early rhythm control is associated with lower risk for CV events as compared to usual care.
Cardiology September 13th 2022